Immunophotonics Announces First Patient Dosed in the United States under its Investigational New Drug (IND) Application
October 10, 2023
Immunophotonics CEO Lu Alleruzzo announced, along with Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as the Principal…
Immunophotonics’ Fast-Track Grant from NIH’s National Cancer institute was granted approval to transition from Phase I to Phase II
September 26, 2023
Immunophotonics was recently granted approval by the NIH’s National Cancer Institute to transition from Phase I to Phase II Fast-track…
Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in France
September 25, 2023
Immunophotonics, Inc. has announced the recruitment and dosing of its first patient in a multinational clinical trial in France at…
RESI Boston 2023 – September 18th
September 14, 2023
Immunophotonics Co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Boston attending the RESI Boston…
CIRSE 2023 September 9 – 13, 2023
September 13, 2023
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be at Booth F18 at the CIRSE…
Immunophotonics Announces 1st Patient Treated in Germany
July 17, 2023
Immunophotonics, Inc. has announced the recruitment and dosing of its first patient in Germany at SLK Kliniken Heilbronn GmbH. The…
Immunophotonics Announces 1st Patient Dosed in Multinational Clinical Trial in the United Kingdom
June 1, 2023
Immunophotonics, Inc. has announced the recruitment and the dosing of its first patient in a multinational clinical trial in the…
SACHS Forum and ASCO Annual Meeting in Chicago June 2 – 6, 2023
June 1, 2023
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Chicago at the SACHS 9th…
Immunophotonics Receives Green Light from FDA to Open Investigational New Drug (IND) Study for IP-001 in the U.S.
May 18, 2023
Immunophotonics has announced the FDA’s decision to allow the U.S. clinical trial of IP-001 to proceed with the enrollment of…
Swiss Biotech Day 2023 April 24 & 25
April 20, 2023
Immunophotonics is pleased to announce its participation at the Swiss Biotech Day in Basel, Switzerland where VP of Business Development…